SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-24-000036
Filing Date
2024-03-21
Accepted
2024-03-20 18:32:04
Documents
18
Period of Report
2024-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240320.htm   iXBRL 8-K 60767
2 EX-10.1 a101-lifecoreceoofferletter.htm EX-10.1 36623
3 EX-10.2 a102-lifecoreequityinducem.htm EX-10.2 126353
4 EX-10.3 a103-hallseparationagreeme.htm EX-10.3 52484
5 EX-99.1 a991-lfcrcomprehensivepr03.htm EX-99.1 20415
9 image_0.jpg GRAPHIC 56620
  Complete submission text file 0001005286-24-000036.txt   562397

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240320.xsd EX-101.SCH 1983
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240320_lab.xml EX-101.LAB 21885
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240320_pre.xml EX-101.PRE 12591
21 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240320_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 24768933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)